Michael Kukulka

1.0k total citations
28 papers, 802 citations indexed

About

Michael Kukulka is a scholar working on Surgery, Gastroenterology and Molecular Biology. According to data from OpenAlex, Michael Kukulka has authored 28 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 16 papers in Gastroenterology and 4 papers in Molecular Biology. Recurrent topics in Michael Kukulka's work include Gastroesophageal reflux and treatments (16 papers), Helicobacter pylori-related gastroenterology studies (16 papers) and Gastrointestinal motility and disorders (7 papers). Michael Kukulka is often cited by papers focused on Gastroesophageal reflux and treatments (16 papers), Helicobacter pylori-related gastroenterology studies (16 papers) and Gastrointestinal motility and disorders (7 papers). Michael Kukulka collaborates with scholars based in United States, United Kingdom and Germany. Michael Kukulka's co-authors include A. David Rodrigues, J. J. PLATTNER, Paolo Baroldi, Daniel W. Norbeck, David Pizzuti, Jon F. Denissen, John M. Leonard, Gondi Kumar, A. David Rodrigues and Kennan C. Marsh and has published in prestigious journals such as Gastroenterology, Analytical Biochemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Michael Kukulka

28 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Kukulka United States 14 256 237 187 177 164 28 802
J H Lin United States 13 209 0.8× 192 0.8× 80 0.4× 38 0.2× 23 0.1× 17 769
Clement Maurath United States 11 377 1.5× 110 0.5× 315 1.7× 201 1.1× 44 0.3× 14 1.3k
Brian Grabowski United States 10 340 1.3× 99 0.4× 204 1.1× 115 0.6× 10 0.1× 14 731
Rick Greupink Netherlands 24 178 0.7× 163 0.7× 33 0.2× 134 0.8× 31 0.2× 70 1.4k
Cheri E. Klein United States 16 293 1.1× 106 0.4× 106 0.6× 89 0.5× 8 0.0× 34 930
Elizabeth K. Hussey United States 19 295 1.2× 62 0.3× 143 0.8× 165 0.9× 9 0.1× 39 983
Poe‐Hirr Hsyu United States 16 152 0.6× 151 0.6× 55 0.3× 84 0.5× 11 0.1× 32 892
Mary Beth Wire United States 18 325 1.3× 55 0.2× 170 0.9× 32 0.2× 14 0.1× 36 957
Keith Erdman United States 7 327 1.3× 96 0.4× 234 1.3× 21 0.1× 19 0.1× 9 504
Angela Äbelö Sweden 12 122 0.5× 195 0.8× 18 0.1× 108 0.6× 110 0.7× 26 541

Countries citing papers authored by Michael Kukulka

Since Specialization
Citations

This map shows the geographic impact of Michael Kukulka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kukulka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kukulka more than expected).

Fields of papers citing papers by Michael Kukulka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kukulka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kukulka. The network helps show where Michael Kukulka may publish in the future.

Co-authorship network of co-authors of Michael Kukulka

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kukulka. A scholar is included among the top collaborators of Michael Kukulka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kukulka. Michael Kukulka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mulford, Darcy J., et al.. (2019). Development of Dexlansoprazole Delayed-Release Capsules, a Dual Delayed-Release Proton Pump Inhibitor. Journal of Pharmaceutical Sciences. 108(11). 3496–3501. 13 indexed citations
2.
Kukulka, Michael, Sai Nudurupati, & María Claudia Pérez. (2018). Bioavailability of dexlansoprazole delayed-release capsule granules when administered via nasogastric tube or orally via syringe. Clinical and Experimental Gastroenterology. Volume 11. 381–389. 2 indexed citations
3.
Kukulka, Michael, Sai Nudurupati, & María Claudia Pérez. (2017). Bioavailability of a dexlansoprazole delayed-release orally disintegrating tablet: effects of food and mode of administration. Clinical and Experimental Gastroenterology. Volume 10. 47–56. 2 indexed citations
4.
Kukulka, Michael, Sai Nudurupati, & María Claudia Pérez. (2016). Bioavailability, safety, and pharmacodynamics of delayed-release dexlansoprazole administered as two 30 mg orally disintegrating tablets or one 60 mg capsule. Therapeutic Advances in Gastroenterology. 9(6). 770–780. 3 indexed citations
5.
Kukulka, Michael, Sai Nudurupati, & María Claudia Pérez. (2014). Pharmacokinetics and safety of dexlansoprazole MR in pediatric patients with symptomatic gastroesophageal reflux disease. Clinical and Experimental Gastroenterology. 7. 461–461. 3 indexed citations
6.
Czerniak, Richard, Michael Kukulka, Jing Wu, & Ping Qiu. (2014). Effects of peginesatide injection on QTc interval in healthy adults. Clinical Pharmacology in Drug Development. 3(6). 449–455. 3 indexed citations
7.
8.
Kukulka, Michael, et al.. (2011). Comparator pH study to evaluate the single-dose pharmacodynamics of dual delayed-release dexlansoprazole 60 mg and delayed-release esomeprazole 40 mg. Clinical and Experimental Gastroenterology. 4. 213–213. 31 indexed citations
9.
Khosravan, Reza, Michael Kukulka, Jingtao Wu, Nancy Joseph‐Ridge, & Laurent Vernillet. (2008). The Effect of Age and Gender on Pharmacokinetics, Pharmacodynamics, and Safety of Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase. The Journal of Clinical Pharmacology. 48(9). 1014–1024. 40 indexed citations
10.
Zhang, Weijiang, et al.. (2008). Age-Dependent Pharmacokinetics of Lansoprazole in Neonates and Infants. Pediatric Drugs. 10(4). 265–274. 21 indexed citations
11.
Metz, David C., et al.. (2006). Lansoprazole regimens that sustain intragastric pH >6.0: an evaluation of intermittent oral and continuous intravenous infusion dosages. Alimentary Pharmacology & Therapeutics. 23(7). 985–995. 27 indexed citations
12.
Howden, Colin W., et al.. (2006). Dose–response evaluation of the antisecretory effect of continuous infusion intravenous lansoprazole regimens over 48 h. Alimentary Pharmacology & Therapeutics. 23(7). 975–984. 13 indexed citations
13.
Vakily, Majid, et al.. (2005). Coadministration of Lansoprazole and Naproxen Does Not Affect the Pharmacokinetic Profile of Methotrexate in Adult Patients With Rheumatoid Arthritis. The Journal of Clinical Pharmacology. 45(10). 1179–1186. 30 indexed citations
14.
Khosravan, Reza, et al.. (2005). Effects of age and gender on febuxostat pharmacokinetics, pharmacodynamics, and safety in healthy subjects. Clinical Pharmacology & Therapeutics. 77(2). P50–P50. 4 indexed citations
15.
Gremse, David A., et al.. (2004). A novel option for dosing of proton pump inhibitors: dispersion of lansoprazole orally disintegrating tablet in water via oral syringe. Alimentary Pharmacology & Therapeutics. 19(11). 1211–1215. 16 indexed citations
16.
Freston, James W., et al.. (2004). A novel option in proton pump inhibitor dosing: lansoprazole orally disintegrating tablet dispersed in water and administered via nasogastric tube. Alimentary Pharmacology & Therapeutics. 20(4). 407–411. 12 indexed citations
17.
Machinist, Joseph M., Michael Kukulka, & Barbara A. Bopp. (1995). In Vitro Plasma Protein Binding of Zileuton and its N-Dehydroxylated Metabolite. Clinical Pharmacokinetics. 29(Supplement 2). 34–41. 20 indexed citations
18.
Rodrigues, A. David, Michael Kukulka, J L Ferrero, & John R. Cashman. (1995). In vitro hepatic metabolism of ABT-418 in chimpanzee (Pan troglodytes). A unique pattern of microsomal flavin-containing monooxygenase-dependent stereoselective N'-oxidation.. Drug Metabolism and Disposition. 23(10). 1143–1152. 16 indexed citations
19.
Rodrigues, A. David, Darcy J. Mulford, Bruce W. Surber, et al.. (1995). In vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.. Drug Metabolism and Disposition. 23(7). 765–775. 58 indexed citations
20.
Rodrigues, A. David, Michael Kukulka, Bruce W. Surber, et al.. (1994). Measurement of Liver Microsomal Cytochrome P450 (CYP2D6) Activity Using [O-methyl-14C] Dextromethorphan. Analytical Biochemistry. 219(2). 309–320. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J H Lin Breakdown of academic impact, for papers by Clement Maurath Breakdown of academic impact, for papers by Brian Grabowski Breakdown of academic impact, for papers by Rick Greupink Breakdown of academic impact, for papers by Cheri E. Klein Breakdown of academic impact, for papers by Elizabeth K. Hussey Breakdown of academic impact, for papers by Poe‐Hirr Hsyu Breakdown of academic impact, for papers by Mary Beth Wire Breakdown of academic impact, for papers by Keith Erdman Breakdown of academic impact, for papers by Angela Äbelö
Rankless by CCL
2026